GlaxoSmithKline has set aside almost £19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …
Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

